🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neutropenia

Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site📍 Memphis St. Jude Children's Research Hospital Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors NCT06926751Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Telpegfilgrastim Injection, filgrastim Serial Blood Count Study NCT07066085EARLY Phase 11 site📍 Seattle University of Washington · Tests: Serial Blood Count Study, Athelas Home device Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection NCT07434063n/a1 site📍 Shijiazhuang Hebei Medical University Fourth Hospital · Tests: Mecapegfilgrastim Injection Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform NCT06999954n/a1 site📍 Woburn Shwachman-Diamond Syndrome Alliance Inc Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia NCT04005638n/a1 site📍 Pessac University Hospital, Bordeaux · Tests: blood sample, urine sample Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy NCT06857292Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Telpegfilgrastim Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer NCT06616987Phase 21 site📍 Seoul Yeon Hee Park · Tests: Sacituzumab Govitecan with pegfilgrastim A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections NCT06056297Phase 3114 sites📍 Phoenix📍 Irvine📍 La Jolla X4 Pharmaceuticals · Tests: Mavorixafor, Placebo Danish Elder Lymphoma Patient Hematopoietic Investigation NCT05245487n/a1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: DNA repair gene mutation analysis UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia NCT06245746Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo) Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data NCT07877727n/a4 sites📍 Avellino📍 Genova📍 Naples Istituto Giannina Gaslini Breath Analysis for the Detection of Invasive Fungal Infections NCT06537726n/a1 site📍 Zurich University of Zurich · Tests: Secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS) Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients. NCT07204522n/a1 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Carbapenems, Anti-Gram-positive agent, Antifungal agent, Ceftazidime-avibactam + Aztreonam Next-Generation-Sequencing Approach to Neutropenic Sepsis NCT05815628n/a6 sites📍 Cologne📍 Dessau📍 Essen Boris Böll · Tests: DISQVER Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever NCT04270786NA1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Early de-escalation, Standard Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia NCT05537896Phase 21 site📍 Morgantown West Virginia University · Tests: Eravacycline Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens NCT06342115Phase 41 site📍 São Paulo Beneficência Portuguesa de São Paulo · Tests: Ceftolozane-Tazobactam, Meropenem Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries. NCT06809101n/a5 sites📍 Næstved📍 Greifswald📍 Rostock Pomeranian Medical University Szczecin Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients NCT07372131NA1 site📍 Rozzano Valeria Cento · Tests: Clinical Stability-Driven Antibiotic Discontinuation Strategy, Standard of Care Antibiotic Duration Study of Trilaciclib and Lurbinectidin NCT05578326Phase 22 sites📍 Lebanon📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Trilaciclib, Lurbinectedin Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients NCT05940766NA1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Automated fever alerts Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor NCT07096479n/a2 sites📍 Hefei📍 Hefei Anhui Provincial Hospital · Tests: Telpegfilgrastim Injection Phase II Study of QLC2519 in Pediatric Solid Tumor Participants NCT07724756Phase 21 site📍 Beijing Qilu Pharmaceutical Co., Ltd. · Tests: Albipagrastim alf Luspatercept for Clonal Cytopenias of Uncertain Significance NCT06788691Phase 21 site📍 New York Weill Medical College of Cornell University · Tests: Luspatercept Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children NCT07725263n/a1 site📍 Haikou Haikou Affiliated Hospital of Central South University Xian… · Tests: Liposomal Amphotericin B (LAmB) Cologne Cohort of Neutropenic Patients (CoCoNut) NCT01821456n/a1 site📍 Cologne University Hospital of Cologne · Tests: Antiinfectives Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia NCT07277387n/a3 sites📍 Barcelona📍 Salamanca📍 Seville Instituto de Investigación Biomédica de Salamanca · Tests: Plasma and DNA sample collection for proteomic and genomic analysis Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers NCT07300735NA1 site📍 Alexandria Alexandria University · Tests: Loratadine, Diosmin-Hesperidin, Loratadine + Diosmin-Hesperidin Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN NCT07187908Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: Efbemalenograstim alfa Injection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy